Role of protein kinase C in endothelin-1-induced contraction of human myometrium. 1998

M Breuiller-Fouché, and C Tertrin-Clary, and V Héluy, and T Fournier, and F Ferré
Institut National de la Santé et de la Recherche Médicale, Unité 361, Université René-Descartes, Paris, France. u361@cochin.inserm.fr

The role of protein kinase C (PKC) in the contraction of human myometrium induced by endothelin-1 was investigated. The PKC inhibitor, calphostin C, reduced the sustained phase of endothelin-1-induced contraction. The expression and subcellular distribution of PKC isoforms were determined in unstimulated myometrium by Western blotting using isoform-specific antisera. At least five PKC isoforms (PKCalpha, PKCbeta1, PKCbeta2, PKCzeta, and trace amounts of PKCepsilon) were detected. Quantitative immunoblotting revealed that all these isoforms were diversely distributed between the cytosolic and particulate fractions. After stimulation with phorbol 12,13-dibutyrate (PDB) and endothelin-1, differential redistribution occurred, suggesting a selective role of these isoforms in the physiological function of the myometrium. Biochemical assay confirmed that PDB as well as endothelin-1 evoked a decrease in cytosolic PKC activity. Taken together, these results suggest that PKC may play a role in endothelin-1-induced contraction of human uterine smooth muscle.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009215 Myometrium The smooth muscle coat of the uterus, which forms the main mass of the organ. Uterine Muscle,Muscle, Uterine,Muscles, Uterine,Uterine Muscles
D009281 Naphthalenes Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Breuiller-Fouché, and C Tertrin-Clary, and V Héluy, and T Fournier, and F Ferré
September 1998, Kidney international. Supplement,
M Breuiller-Fouché, and C Tertrin-Clary, and V Héluy, and T Fournier, and F Ferré
January 1994, Nihon Sanka Fujinka Gakkai zasshi,
M Breuiller-Fouché, and C Tertrin-Clary, and V Héluy, and T Fournier, and F Ferré
December 1995, European journal of pharmacology,
M Breuiller-Fouché, and C Tertrin-Clary, and V Héluy, and T Fournier, and F Ferré
April 1997, The Journal of pharmacology and experimental therapeutics,
M Breuiller-Fouché, and C Tertrin-Clary, and V Héluy, and T Fournier, and F Ferré
November 2000, Biology of reproduction,
M Breuiller-Fouché, and C Tertrin-Clary, and V Héluy, and T Fournier, and F Ferré
September 1998, The American journal of physiology,
M Breuiller-Fouché, and C Tertrin-Clary, and V Héluy, and T Fournier, and F Ferré
February 2001, Hypertension (Dallas, Tex. : 1979),
M Breuiller-Fouché, and C Tertrin-Clary, and V Héluy, and T Fournier, and F Ferré
December 2003, British journal of pharmacology,
M Breuiller-Fouché, and C Tertrin-Clary, and V Héluy, and T Fournier, and F Ferré
October 1992, British journal of pharmacology,
M Breuiller-Fouché, and C Tertrin-Clary, and V Héluy, and T Fournier, and F Ferré
April 1998, European journal of pharmacology,
Copied contents to your clipboard!